Key Metrics
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
-
Scopus -
DOAJ
Topics Covered
- Heart failure
- Fat burning
- Myocardial fibrosis
- Cancer therapy
- Gastric dysmotility
- Airway disease
- Cytokine storm
- Hyperoxia
Journal Specifications
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2500 |
| Publication Time | 10 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 10 |
| Article Processing Charges | USD 2500 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Current Research in Pharmacology and Drug Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Mefloquine-curcumin combinations improve host mitochondrial respiration and decrease mitotoxic effects of mefloquine in Plasmodium berghei-infected mice
- 1 Apr 24
- Current Research in Pharmacology and Drug Discovery
-
Full paper
Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats
- 1 Jan 24
- Current Research in Pharmacology and Drug Discovery
-
Full paper
Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition
- 1 Jan 24
- Current Research in Pharmacology and Drug Discovery
-
Full paper
Long-term effects of neonatal pain and sucrose treatment
- 1 Jan 24
- Current Research in Pharmacology and Drug Discovery
-
Full paper
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
- 1 Jan 24
- Current Research in Pharmacology and Drug Discovery
-
Full paper
Development of Recombinant Antibody by Yeast Surface Display Technology
- 1 Jan 24
- Current Research in Pharmacology and Drug Discovery
Scite analysis
Powered by scite_
175 articles received 726 citations see all
- 12 Supporting
- 697 Mentioning
- 0 Contrasting
Editorial notices
- 1 Retractions
- 1 Withdrawals
- 0 Corrections
- 7 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
21%
4 to 6 months
65%
7 to 9 months
11%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
FAQs
How many articles did Current Research in Pharmacology and Drug Discovery publish last years ?
In 2023, Current Research in Pharmacology and Drug Discovery published 16 articles.
Who is the publisher of Current Research in Pharmacology and Drug Discovery ?
Elsevier is the publisher of Current Research in Pharmacology and Drug Discovery.